|
1H NMR STUDIES OF NON-HODGKINS LYMPHOMA
|
5R01CA101700-06
|
$364,626
|
$364,626
|
GLICKSON, JERRY
|
UNIVERSITY OF PENNSYLVANIA
|
|
A bifunctional nanomedicine for both specific imaging and targeting therapy of an
|
1R01CA151955-01
|
$319,550
|
$319,550
|
ZU, YOULI
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120 02060
|
$889,165
|
$177,833
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
A Comprehensive Investigation of Viral-induced Lymphomagenesis
|
5R01CA121180-05
|
$268,056
|
$268,056
|
FISHER, SUSAN
|
UNIVERSITY OF ROCHESTER
|
|
A Genome-Wide Association Study of Non-Hodgkin Lymphoma
|
5R01CA122663-05
|
$508,204
|
$508,204
|
Skibola, Christine
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera
|
1R01CA139119-01A2
|
$268,920
|
$134,460
|
Chaudhary, Preet
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
ZIA BC 011064
|
$247,511
|
$49,502
|
Mock, Beverly
|
CCR (NCI)
|
|
A novel enzymatic activity of WSTF and its role in tumorigenesis
|
4R00CA131560-03
|
$249,000
|
$249,000
|
XIAO, ZHUO
|
YALE UNIVERSITY
|
|
A novel in vivo test system to evaluate therapeutic antibodies in dog models of s
|
1R43CA150292-01
|
$154,000
|
$154,000
|
Hansen, Genevieve
|
VET THERAPEUTICS, INC.
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$344,821
|
$34,482
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S6
|
$7,064,076
|
$423,845
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S7
|
$100,000
|
$6,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S8
|
$50,000
|
$3,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abrogating human CD59 activity for antibody-based cancer therapy
|
1R21CA141324-01A1
|
$184,331
|
$184,331
|
QIN, XUEBIN
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Academic Training in Medical Oncology
|
5T32CA009297-27
|
$304,451
|
$15,223
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Activation of BCL-2 in Hematologic Malignancies
|
5R01CA056764-16
|
$290,500
|
$290,500
|
BOXER, LINDA
|
PALO ALTO INSTITUTE FOR RES & EDU, INC.
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$289,223
|
$43,384
|
Aplan, Peter
|
CCR (NCI)
|
|
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center
|
3U01CA096230-08S1
|
$100,000
|
$23,000
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
AIDS and Cancer Specimen Resource Central Office and Data Coordinating Center
|
5U01CA096230-08
|
$754,565
|
$173,550
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
AIDS Associated Lymphoproliferative Disorders
|
5R37CA037295-27
|
$402,500
|
$402,500
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
2U01CA121947-04
|
$4,660,100
|
$932,020
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors
|
5R01CA122658-04
|
$585,231
|
$146,308
|
KNOBF, M. Tish
|
YALE UNIVERSITY
|
|
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression
|
5R01CA130752-03
|
$309,175
|
$309,175
|
FLEMINGTON, ERIK
|
TULANE UNIVERSITY OF LOUISIANA
|
|
Analysis of the p53 in vivo using a unique mouse model
|
5R01CA100193-08
|
$345,666
|
$34,567
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Anatomic Pathology Residency Program
|
ZIE BC 010684
|
$1,506,107
|
$150,611
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Animal Model and Genotyping Core Support Facility
|
ZIC BC 011047
|
$995,515
|
$199,103
|
DuBois, Wendy
|
CCR (NCI)
|
|
Annual Primary CNS Lymphoma Collaborative Group Meeting
|
5R13CA124293-05
|
$5,000
|
$5,000
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
|
ZIA BC 010647
|
$377,603
|
$188,802
|
Rader, Christoph
|
CCR (NCI)
|
|
Antibody-based therapeutics and vaccines against AIDS
|
ZIA BC 011155
|
$269,092
|
$134,546
|
Dimitrov, Dimiter
|
CCR (NCI)
|
|
Antibody-CpG conjugates for the treatment of B cell lymphoma
|
1R01CA149254-01
|
$319,550
|
$319,550
|
Timmerman, John
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Antibody-mediated Gene Therapy for the Treatment of Cancer
|
5K01CA138559-02
|
$139,465
|
$139,465
|
Daniels, Tracy
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Antigen Discovery and Development of Tumor-Specific Lymphoma Immunotherapy
|
5K23CA123149-04
|
$136,080
|
$136,080
|
Neelapu, Sattva
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
ATBC Study
|
ZIA CP010195 03031
|
$853,810
|
$93,919
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
B Cell Lymphoma Therapy
|
5R01CA121039-04
|
$244,245
|
$244,245
|
CHOI, YONG
|
OCHSNER CLINIC FOUNDATION
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-04
|
$3,089,219
|
$154,461
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S6
|
$100,000
|
$5,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-04S1
|
$250,400
|
$12,520
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Bcl-2 function on the endoplasmic reticulum
|
2R01CA085804-11A1
|
$130,332
|
$65,166
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
BCR Signaling in ABC DLBCL
|
ZIA BC 011354
|
$88,808
|
$88,808
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Behavioral Science Core
|
ZIC BC 011288
|
$375,769
|
$18,788
|
Wayne, Alan
|
CCR (NCI)
|
|
BETR Therapy for Herpesvirus-Associated Tumors
|
1R01CA138636-01A1
|
$582,447
|
$291,224
|
POMPER, MARTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$771,635
|
$77,163
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,322,152
|
$661,076
|
Samelson, Lawrence
|
CCR (NCI)
|
|
Biologic Therapy for B-cell non-Hodgkin's Lymphoma
|
5R01CA092104-07
|
$258,741
|
$258,741
|
ANSELL, STEPHEN
|
MAYO CLINIC
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$10,002
|
$500
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers of benzene exposure
|
ZIA CP010121 02035
|
$96,758
|
$32,898
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
5P01CA049605-22
|
$3,583,412
|
$1,970,877
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
Breast implant follow-up study
|
ZIA CP010128 01220
|
$31,739
|
$1,587
|
Brinton, Louise
|
DCEG (NCI)
|
|
Bub 1 in Chromosomal Instability and Tumorigenesis
|
5R01CA126828-04
|
$281,200
|
$281,200
|
VAN DEURSEN, JAN
|
MAYO CLINIC
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,188,980
|
$59,449
|
Restifo, Nicholas
|
CCR (NCI)
|
Total relevant funding to Non Hodgkins Lymphoma for this search: $122,350,730
|